PharmaShots | Incisive News in 3 Shots

Subscribe Now

Withdrawal

Agenus Reports the Withdrawal of BLA for Balstilimab to Treat Cervical Cancer

Agenus Reports the Withdrawal of BLA for Balstilimab to Treat Cervical Cancer

October 25, 2021

Ipsen Reports the Withdrawal of NDA for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva

Ipsen Reports the Withdrawal of NDA for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva

August 13, 2021

Pfizer and Myovant Report Results of Relugolix Combination Therapy in P-III LIBERTY Withdrawal Study in Women with Uterine Fibroids

Pfizer and Myovant Report Results of Relugolix Combination Therapy in P-III LIBERTY Withdrawal Study in Women with Uterine Fibroid...

March 25, 2021

Eli Lilly Facilitates the Withdrawal of Lartruvo (olaratumab) from the Global Market for Advanced Soft Tissue Sarcoma

Eli Lilly Facilitates the Withdrawal of Lartruvo (olaratumab) from the Global Market for Advanced Soft Tissue Sarcoma

April 25, 2019

Alcon Announces Global Removal of CyPass Micro-Stent for Surgical Glaucoma

Alcon Announces Global Removal of CyPass Micro-Stent for Surgical Glaucoma

August 29, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us